Synergistic anti‐tumor effect of paclitaxel with CRM197, an inhibitor of HB‐EGF, in ovarian cancerHiroshi Yagi(Kyushu University), Shingo Miyamoto(Fukuoka University)International Journal of CancerSeptember 30, 200810.1002/ijc.24031Cited by 64SaveCiteExport RISWatch citationsRelated PapersNovel screening system revealed that intracellular cholesterol trafficking can be a good target for colon cancer prevention|Scientific Reports|2019|13